MARKET OVERVIEW
RNA Analysis/Transcriptomics is the study of RNA transcripts outturned by genome of any organism, under specific circumstances or in a specific cell using high throughput methods. Comparison of transcriptomes enables in identifying genes that are differentially expressed in distinct cell populations, or in response to different treatments.
MARKET SCOPE
The "Global RNA Analysis/Transcriptomics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the RNA analysis/transcriptomics market with detailed market segmentation by product, technology, application, end user and geography. The report provides key statistics on the market status of the leading RNA analysis/transcriptomics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product, the global RNA Analysis/Transcriptomics market is segmented into consumables, instruments, software and services.
- The technology segment is classified into microarray, real-time quantitative polymerase chain reaction, and sequencing technologies.
- Based on application the market is segmented into diagnostics and disease profiling, drug discovery and others.
- Based on end user the market is segmented into government institutes and academic centers, pharmaceutical and biotechnological companies and contract research organization.
MARKET DYNAMICS
Drivers:
- Increasing advancements in the field of transcriptomics such as advancements in RNA-sequencing technology
- Growth in transcriptomics application
- Increasing funding by various private and government organization
- Increasing number of pharmaceutical and biotechnology companies
- Continuous improvements in the healthcare infrastructure.
Restraints:
- Dearth of skilled professionals
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The RNA analysis/transcriptomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the RNA analysis/transcriptomics market in these regions.
IMPACT OF COVID-19 ON RNA ANALYSIS/TRANSCRIPTOMICS MARKET
All countries across the globe have been highly affected due to the outbreak of the COVID-19 pandemic. Countries such as the US and Canada reported the highest numbers of COVID-19 positive cases. The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for COVID diagnostics and therapeutics have dramatically increased in the hospitals.
The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold.
Further in North America, the COVID-19 pandemic has disrupted scientific research activities significantly. Research Laboratories have been forced to shut down. Researchers have been advised to work from home. Animal facilities have been scaled down and shipping of research supplies has been delayed.
MARKET PLAYERS
The report covers key developments in the RNA analysis/transcriptomics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from RNA analysis/transcriptomics market are anticipated to lucrative growth opportunities in the future with the rising demand for RNA analysis/transcriptomics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the RNA analysis/transcriptomics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- GE Healthcare
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies Inc.
- Thermofisher Scientific Inc.
- Sigma Aldrich
- Qiagen N.V.
- Affymetrix Inc.
- Fluidigm Corporation
RNA Analysis/Transcriptomics Report Scope
Report Attribute | Details |
---|---|
Market size in 2024 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2025 - 2031) | XX% |
Historical Data | 2021-2023 |
Forecast period | 2025-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















1. BioRad Laboratories Inc.
2. Illumina Inc.
3. GE Healthcare
4. F. HoffmannLa Roche Ltd.
5. Agilent Technologies Inc.
6. Thermofisher Scientific Inc.
7. Sigma Aldrich
8. Qiagen N.V.
9. Affymetrix Inc.
10. Fluidigm Corporation


